Date of Publication: 2025-Jul-15

The GLP-1 Market report provides a detailed analysis of the current landscape, outlining key insights into business strategies, market trends, and offering both qualitative and quantitative data. This comprehensive report covers critical aspects of the global market, including exploration of key drivers, challenges, growth prospects, and risks. It also presents an in-depth analysis of the competitive environment and regional variations within the GLP-1 industry.

The global GLP-1 market, valued at USD 49.3 billion in 2024, is estimated to reach USD 62.2 billion in 2025 and USD 157.5 billion by 2035, representing a CAGR of 9.7% during the forecast period.  The study outlines key market segments and how they are evolving. It covers a range of important factors impacting the market, such as the introduction of new GLP-1 products, the expansion of market reach by existing companies, and changes in market demand. Strategic movements like mergers, acquisitions, product introductions, and partnerships are explored, offering a comprehensive view of how the market landscape is shifting. The report delivers insightful data on how companies are responding to these changes.

The GLP-1 Market is segmented by several factors,

Type of Molecule

• Biologics

• Small Molecules

Active Compound Used

• Dulaglutide 

• Liraglutide

• Orforglipron 

• Retatrutide

• Semaglutide 

• Survodutide

• Tirzepatide

• Other Active Compounds

Type of GLP-1 Agonist Drugs

• Long-acting GLP-1 Agonist

• Short-acting GLP-1 Agonist

Type of Agonist

• Single agonist

• Dual agonist

• Tri-agonist

Route of Administration

• Oral

• Parenteral

Key Geographical Regions

• North America

•  
  • US

•  
  • Canada

• Europe

•  
  • Germany

•  
  • UK

•  
  • France

•  
  • Italy

•  
  • Spain

•  
  • Netherlands

•  
  • Rest of Europe

• Asia Pacific

• Latin America

Key Companies Profiled

• AstraZeneca

• Biolingus

• Boehringer Ingelheim

• D&D Pharmatech

• Eli Lilly

• Gmax Biopharm

• Hanmi Pharmaceutical

• Innogen

• Novo Nordisk

• PegBio

• Pfizer

• QL Biopharma

• Roche

• Sanofi

• Sciwind Biosciences

• Tonghua Dongbao Pharmaceutical

• Viking Therapeutics

• Vivani

• vTv Therapeutic

The GLP-1 Market is analyzed across various regions, Key Geographical North America, Europe, Asia-Pacific, Middle East and North Africa. Each of these regions presents unique market dynamics, reflecting varying levels of market penetration, demand for sustainable agricultural practices, and local regulations that influence the adoption of GLP-1 solutions.

source of information: https://www.rootsanalysis.com/reports/glp-1-market.html

Key companies in the GLP-1 Market include AstraZeneca, Biolingus, Boehringer Ingelheim, D&D Pharmatech, Eli Lilly, Gmax Biopharm, Hanmi Pharmaceutical, Innogen, Novo Nordisk, PegBio, Pfizer, QL Biopharma, Roche, Sanofi, Sciwind Biosciences, Tonghua Dongbao Pharmaceutical, Viking Therapeutics, Vivani, vTv Therapeutic. These industry leaders are committed to driving the market forward through innovation, with a focus on developing new and more effective GLP-1 products. Their strategies, which include strategic partnerships, mergers, and new product launches, are instrumental in expanding their reach and improving market share.

The report further provides an analysis of the GLP-1 industry using frameworks such as analysis from the ToC such as partnerships, recent expansions, helping to identify key areas of competition, potential risks, and strategic opportunities. This analysis gives stakeholders a deeper understanding of the market environment, providing crucial insights that can guide decision-making processes.

In conclusion, this report offers a comprehensive overview of the GLP-1 Market, shedding light on market trends, regional dynamics, and the competitive landscape. By providing a detailed analysis of current market conditions and prospects, this report serves as an essential resource for stakeholders seeking to navigate the evolving GLP-1 industry and make informed business decisions.

About Roots Analysis

Who Are They

1. Roots Analysis is a globally recognized provider of market intelligence, competitive research, and consulting services.
2. With 12+ years of experience, the company has worked with 750+ clients across the globe — including Fortune 500 companies, emerging start-ups, academic institutions, and strategic investors.
3. Backed by a network of 450,000+ senior professionals, Roots Analysis delivers data-driven insights that guide business-critical decisions.
4. The firm serves a diverse set of high-impact industries, including Life Sciences, Semiconductors & Electronics, Chemicals & Materials, and Information & Communication Technology (ICT), making them a trusted partner across innovation-driven sectors.
5. The firm is known for quality of their research, completeness and depth of the research. The team is actively working with numerous global clients to support key decision-makers, smart insights for revenue impact decisions, strategic growth.

What They Do

1. Roots Analysis helps organizations understand and respond to evolving markets and emerging technologies.
2. They offer data-backed insights that support informed decision-making and long-term strategy development.
3. Their team continuously monitors innovation and disruption across high-impact sectors, identifying growth opportunities early on.

What They Offer

1. Syndicated Market Reports – Structured, in-depth reports covering niche and fast-evolving markets.
2. Custom Research & Consulting – Bespoke studies designed to align with specific business goals and challenges.
3. Competitive Intelligence Solutions – Deep market mapping, pipeline analysis, partnership tracking, and investor profiling.

What Sets Them Apart

1. Sector Expertise – Especially strong in pharmaceuticals, biotechnology, healthcare, and deep tech.
2. Analytical Strength – Research is grounded in robust methodologies, real-world data, and strategic foresight.
3. Client-Centric Approach – Every engagement is tailored, no generic solutions.
4. Global Credibility – Trusted by decision-makers and thought leaders around the world.
5. Forward-Looking Vision – Roots Analysis focuses not just on where markets are, but where they’re heading.

Contact Details for Roots Analysis

Chief Executive:  Gaurav Chaudhary

Email:  Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com